A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

The global neuromodulation device market will be worth $11.4bn by 2033, as per a market model from GlobalData.

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

For so long, we had a drought when it came to treatment options for Alzheimer's, until the last few years when we've seen two ...

Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked. Among a group ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Dementia is a debilitating neurodegenerative disease that gradually diminishes life quality, leading to memory loss, ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...